Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GGT1 | P19440 | 1/20 | 0.38 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
| ▸ | ARG1 | P05089 | 1/20 | 0.34 |
| ▸ | ARG2 | P78540 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL797973 | 0.82 | TSHR (0.47) | ALDH1A1TSHRGGT1ACLYCYP2D6 | |
| SCHEMBL13262289 | 0.78 | ALDH1A1 (0.33) | ALDH1A1BLMGRM4GAAMAPT | |
| SCHEMBL8273528 | 0.78 | GRM4 (0.32) | ALDH1A1CYP2C19BLMCYP1A2KMT2A | |
| SCHEMBL24130510 | 0.77 | TSHR (0.39) | ALDH1A1TSHRGGT1ACLYCYP2D6 | |
| SCHEMBL13442790 | 0.77 | MEN1 (0.39) | ALDH1A1TSHRGGT1ACLYCYP2D6 | |
| SCHEMBL85014 | 0.77 | TSHR (0.42) | ALDH1A1TSHRGGT1ACLYCYP2D6 | |
| SCHEMBL22013342 | 0.76 | GRM4 (0.31) | GRM4 | |
| SCHEMBL14341015 | 0.76 | TSHR (0.36) | ALDH1A1TSHRACLYCYP2D6CYP2C19 | |
| SCHEMBL14458885 | 0.76 | GRM4 (0.31) | GRM4 | |
| SCHEMBL12066145 | 0.76 | TSHR (0.36) | ALDH1A1TSHRGGT1ACLYCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12043755-B2 | Compositions, methods, and articles relating to in-situ crosslinking of polyamides during additive manufacturing | XEROX CORPORATION (US) | 2024-07-23 | — | — | US | disclosed |
| EP-3645505-B1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | VITAWORKS IP LLC (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-3645502-B1 | PROCESS FOR THE SEPARATION OF LONG CHAIN AMINO ACIDS AND DIBASIC ACIDS | VITAWORKS IP LLC (US) | 2023-08-23 | — | — | EP | disclosed |
| WO-2023111350-A2 | CARBONIC ANHYDRASE IX LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-06-22 | — | — | WO | disclosed |
| US-11668704-B2 | Degradation preventing means for immunoassay reagent containing insoluble carrier particles | FUJIKURA KASEI CO., LTD. (JP) | 2023-06-06 | — | — | US | disclosed |
| EP-4170347-A1 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B Pharmaceuticals GmbH (DE) | 2023-04-26 | — | — | EP | disclosed |
| EP-3652149-B1 | PROCESS FOR PRODUCING LONG CHAIN ACIDS AND DIBASIC ACIDS | VITAWORKS IP LLC (US) | 2022-12-28 | — | — | EP | disclosed |
| US-20220162474-A1 | COMPOSITIONS, METHODS, AND ARTICLES RELATING TO IN-SITU CROSSLINKING OF POLYAMIDES DURING ADDITIVE MANUFACTURING | XEROX CORPORATION (US) | 2022-05-26 | — | — | US | disclosed |
| US-11177440-B2 | Method for inkjet printing an organic-inorganic perovskite | AALTO UNIVERSITY FOUNDATION (FI) | 2021-11-16 | — | — | US | disclosed |
| US-20210123907-A1 | DEGRADATION PREVENTING MEANS FOR IMMUNOASSAY REAGENT CONTAINING INSOLUBLE CARRIER PARTICLES | FUJIKURA KASEI CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
| US-20100330086-A1 | CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-12-30 | — | — | US | disclosed |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | disclosed |
| WO-2009021944-A1 | NEW COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-02-19 | — | — | WO | disclosed |
| WO-2009021758-A1 | ARYLSULFONAMIDES HAVING AN ANALGESIC EFFECT | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-02-19 | — | — | WO | disclosed |
| WO-2009021946-A1 | NOVEL COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-02-19 | — | — | WO | disclosed |
| EP-2025673-A1 | Arylsulfonamides with analgetic activity | Boehringer Ingelheim International GmbH (DE) | 2009-02-18 | — | — | EP | disclosed |
| EP-2025675-A1 | Arylsulfonamides with analgetic activity | Boehringer Ingelheim International GmbH (DE) | 2009-02-18 | — | — | EP | disclosed |
| EP-2025668-A1 | Arylsulfonamides with analgetic activity | Boehringer Ingelheim International GmbH (DE) | 2009-02-18 | — | — | EP | disclosed |
| WO-2008022945-A1 | ARYL SULFONAMIDES WITH AN ANALGESIC ACTION | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-02-28 | — | — | WO | disclosed |
| US-20070191322-A1 | Cationic Steroid Microbial Compositions and Methods of Use | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100330086-A1 | CATIONIC STEROID ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | CCL5, PRF1, NR3C1 | ALDH1A1 4393/4885TSHR 3961/4885GGT1 1919/4885 |
| US-11668704-B2 | Degradation preventing means for immunoassay reagent containing insoluble carrier particles | LTC4S, ALOX5, ALOX15 | ALDH1A1 188/4885TSHR 4524/4885GGT1 372/4885 |
| US-20070191322-A1 | Cationic Steroid Microbial Compositions and Methods of Use | CCL5, NR3C1, NR3C2 | ALDH1A1 4197/4885TSHR 2236/4885GGT1 2470/4885 |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | SLC6A7, DNPEP, PREP | ALDH1A1 2968/4885TSHR 2864/4885GGT1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.